Paloma Partners’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,315
Closed -$133K 616
2024
Q3
$133K Sell
2,315
-7,585
-77% -$435K ﹤0.01% 1026
2024
Q2
$518K Buy
+9,900
New +$434K 0.01% 739
2021
Q2
Sell
-10,839
Closed -$451K 1981
2021
Q1
$451K Buy
+10,839
New +$495K 0.01% 1197
2020
Q4
Sell
-23,159
Closed -$609K 1869
2020
Q3
$609K Buy
+23,159
New +$645K 0.02% 1028
2020
Q1
Sell
-25,742
Closed -$456K 1570
2019
Q4
$456K Buy
+25,742
New +$446K 0.01% 1465
2019
Q1
Sell
-10,277
Closed -$150K 1779
2018
Q4
$150K Buy
+10,277
New +$164K ﹤0.01% 1089
2018
Q2
Sell
-45,130
Closed -$885K 1863
2018
Q1
$885K Buy
+45,130
New +$874K 0.01% 1053
2017
Q3
Sell
-42,849
Closed -$549K 2216
2017
Q2
$549K Buy
42,849
+22,162
+107% +$296K 0.01% 1496
2017
Q1
$268K Buy
+20,687
New +$261K ﹤0.01% 1776
2015
Q4
Sell
-13,700
Closed -$184K 1789
2015
Q3
$184K Buy
+13,700
New +$275K ﹤0.01% 1478
2015
Q1
Sell
-14,226
Closed -$137K 1282
2014
Q4
$137K Buy
+14,226
New +$126K 0.01% 1049

Other funds holding HALO

Paloma Partners's HALO Position: Q4 2024 in Review

Paloma Partners sold out of Halozyme (HALO) in Q4 2024, closing a stake of 2,315 shares — an estimated $133K sold.

Paloma Partners first reported a position in HALO in Q4 2014 and held it in 11 quarters. The position peaked at $885K in Q1 2018. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Paloma Partners reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 2,315 Halozyme shares in Q4 2024, an estimated $133K.
  • Paloma Partners first reported a position in Halozyme in Q4 2014 and held it in 11 quarters.
  • Paloma Partners's Halozyme position peaked at $885K in Q1 2018.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.